These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 7221493)
21. [Effect of cuprenil (D-penicillamine) treatment on the clinical course of rheumatoid arthritis]. Małdykowa H; Chwalińska-Sadowska H; Zajzczek-Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T Reumatologia; 1981; 19(2):189-95. PubMed ID: 7034105 [No Abstract] [Full Text] [Related]
22. [Changes in various humoral immunity indicators during the treatment of rheumatoid arthritis with D-penicillamine (cuprenil)]. Chwalińska-Sadowska H; Małdykowa H; Zajaczek-Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T; Swierczyńska Z; Orłowska G; Rdułtowska H; Luft S; Rogozińska E Reumatologia; 1981; 19(2):151-7. PubMed ID: 6459630 [No Abstract] [Full Text] [Related]
23. Response of rheumatoid arthritis to chemotherapy for Hodgkin's disease in a patient with IgA deficiency and overlap connective tissue disease. Cohen MG; Janssen B; Webb J Ann Rheum Dis; 1988 Jul; 47(7):603-5. PubMed ID: 3401058 [TBL] [Abstract][Full Text] [Related]
24. [Pemphigus caused by D-penicillamine]. Benito Urbina S; Chávez Calvo M; Riesco Diáz M; Peláez Domínguez S; de la Prada Arroyo M Rev Clin Esp; 1982 Sep; 166(5):249-50. PubMed ID: 7146547 [No Abstract] [Full Text] [Related]
25. C1 inhibitor deficiency in a patient with rheumatoid arthritis--increased risk of adverse effects of penicillamine? Sturfelt G; Rydgren L; Truedsson L; Alm P; Sjöholm AG J Rheumatol; 1996 Feb; 23(2):378-81. PubMed ID: 8882051 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of the major metabolites of D-penicillamine in patients with rheumatoid arthritis. Carruthers G; Harth M; Freeman D; Weir D; Rothwell R; Butler M Clin Invest Med; 1984; 7(1):35-40. PubMed ID: 6723122 [TBL] [Abstract][Full Text] [Related]
27. Pyrithioxine and thiopronine: new penicillamine-like drugs in rheumatoid arthritis. Camus JP; Crouzet J; Prier A; Bergevin H J Rheumatol Suppl; 1981; 7():175-7. PubMed ID: 6939882 [TBL] [Abstract][Full Text] [Related]
28. [Use of D-penicillamine for the treatment of rheumatoid arthritis and the study of various mechanisms of its action]. Trofimova TM; Panasiuk AF; Avdeeva ZhI; Tarasenkova TA; Astakhova TA Ter Arkh; 1980; 52(6):110-3. PubMed ID: 7404375 [No Abstract] [Full Text] [Related]
29. Drug-induced IgA deficiency in rheumatoid arthritis. Stanworth DR; Williamson JP; Shadforth M; Felix-Davies D; Thompson R Lancet; 1977 May; 1(8019):1001-2. PubMed ID: 67433 [No Abstract] [Full Text] [Related]
30. [Selective and generalized hypogammaglobulinemia in patients with rheumatoid arthritis in treatment with gold salts]. Bambara LM; Biasi D; Caramaschi P; Codella O; De Sandre G Ann Ital Med Int; 1986 Dec; 1(4):298-302. PubMed ID: 3275190 [No Abstract] [Full Text] [Related]
31. [Basic therapy of rheumatoid arthritis with D-penicillamine. Personal contribution and critical observations]. Gigante D; Teodori S; Crispo M Fortschr Med; 1983 Apr; 101(13):613-8. PubMed ID: 6852728 [No Abstract] [Full Text] [Related]
33. [Efficacy of D-penicillamine and methotrexate in the treatment of rheumatoid arthritis in relation to levels of circulating rheumatoid factors of different classes]. Zborovskiĭ AB; Sivordova LE; Derevianko LI; Zborovskaia IA; Zavodovskiĭ BV Ter Arkh; 1999; 71(1):60-3. PubMed ID: 10097305 [TBL] [Abstract][Full Text] [Related]